EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 200 filers reported holding EDITAS MEDICINE INC in Q1 2018. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $245,000 | -34.1% | 5,959 | -9.3% | 0.01% | -39.1% |
Q2 2021 | $372,000 | +48.8% | 6,570 | +10.6% | 0.02% | +91.7% |
Q1 2021 | $250,000 | -8.4% | 5,942 | +52.4% | 0.01% | -14.3% |
Q4 2020 | $273,000 | +150.5% | 3,900 | 0.0% | 0.01% | +40.0% |
Q3 2020 | $109,000 | -6.0% | 3,900 | -0.1% | 0.01% | -9.1% |
Q2 2020 | $116,000 | +954.5% | 3,905 | +700.2% | 0.01% | +1000.0% |
Q1 2020 | $11,000 | -62.1% | 488 | -49.6% | 0.00% | -66.7% |
Q4 2019 | $29,000 | +163.6% | 968 | +98.4% | 0.00% | +200.0% |
Q3 2019 | $11,000 | -15.4% | 488 | -7.6% | 0.00% | 0.0% |
Q2 2019 | $13,000 | 0.0% | 528 | 0.0% | 0.00% | -50.0% |
Q1 2019 | $13,000 | +333.3% | 528 | +359.1% | 0.00% | – |
Q4 2018 | $3,000 | 0.0% | 115 | 0.0% | 0.00% | – |
Q3 2018 | $3,000 | +200.0% | 115 | +187.5% | 0.00% | – |
Q2 2018 | $1,000 | -50.0% | 40 | -33.3% | 0.00% | – |
Q1 2018 | $2,000 | 0.0% | 60 | -25.0% | 0.00% | – |
Q4 2017 | $2,000 | 0.0% | 80 | 0.0% | 0.00% | – |
Q3 2017 | $2,000 | – | 80 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |